Moderna Inc (NAS:MRNA)
$ 125.7 8.36 (7.13%) Market Cap: 48.17 Bil Enterprise Value: 37.67 Bil PE Ratio: 0 PB Ratio: 3.75 GF Score: 68/100

Moderna Inc Science Day Transcript

May 27, 2021 / 12:00PM GMT
Release Date Price: $179.54 (+2.25%)
Lavina Talukdar
Moderna, Inc. - Senior VP & Head of IR

Good morning, and welcome to Moderna's Fourth Annual Science Day. Today, you will be hearing from our scientists in platform research and their work enabling the discovery and development of our mRNA medicines and vaccines.

Following the formal presentations, we will take your questions during the Q&A section. You can access the press release issued this morning as well as the presentation slides by going to the Investors section of our website. On today's call are Stephane Bancel, our Chief Executive Officer; Stephen Hoge, our President; Melissa Moore, our Chief Scientific Officer of Platform Research; and the scientists representing the broader platform research team.

Before we begin, please note that today's presentation will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and our SEC filings for important risk factors that could cause our actual performance and results to differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot